Sign up
Pharma Capital

Judges Scientific PLC - 2018 Interim Results

Judges Scientific reported results for the first half of 2018. The period included a first-time contribution from Oxford Cryosystems, which was acquired in July 2017. Organic growth of order intake and sales was solid and well in line with the full year target.
Judges Scientific PLC - 2018 Interim Results

The group’s adjusted operating profit grew 48% Y/Y to £6.9mln; the vacuum segment’s performance was noteworthy, with a significant increase of 26% and 89% for revenue and operating profit respectively lifting the segment’s adjusted operating margin to 23% from 15% in 1H 2017. Such a notable profit increase was thanks to a continued operational improvement, the new earnings contribution from Oxford Cryosystems, and an increased shareholding at Bordeaux.

Full report is available via Capital Network website

Register here to be notified of future JDG Company articles
View full JDG profile View Profile
CN Video

Helaine Kang on Judges Scientific PLC

CN Research

Judges Scientific PLC - FY 2017 Results

View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.